我要投票 金日在燕窝行业中的票数:766
· 外 推 电 报 ·
2026-01-08 23:17:57 星期四

【金日是哪个国家的品牌?】

金日是什么牌子?「金日」是金日制药(中国)有限公司旗下著名品牌。该品牌发源于福建,由创始人李冠华在1991期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力金日品牌出海!将品牌入驻外推网,定制金日品牌推广信息,可以显著提高金日产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

金日,是一家有二十多年历史,集制药、医疗、保健、金融、贸易、房地产为一体的多元化实业集团,拥有香港及内地十几家下属企业,并在新加坡、加拿大等地进行各类投资贸易活动.已在国内厦门、福州、顺德、深圳等地设立制造基地,总投资已达10亿元人民币.1986年,公司开始在中国内地生产“金日牌”系列医药保健品.集团全资子公司“厦门金日制药有限公司”创办于1991年,现拥有口服液、片剂、胶囊剂、颗粒剂、凝膏剂、浸膏剂、乳膏剂、巴布膏剂、膜剂等9条符合国际药品GMP标准的生产线,是福建省最具规模的整体通过国家药品GMP认证的现代化制药企业.

20多年的品牌建设,已使“金日牌”系列产品享誉海内外,“金日牌”洋参已成为中国洋参行业知名品牌,,被誉为东南亚“西洋参之王”;“金日心源素”已成为中国心脑保健第一品牌.公司的发展历程得到了李瑞环、万里、杨成武、王光英、王兆国、钱伟长、万国权、王汉斌、程思远、布赫、吴阶平等党和国家领导人的肯定和赞扬.公司先后被评为厦门外商投资企业二十佳、福建省医药十强、中国保健食品五十强企业、全国百家明星侨资企业,并连续五年纳税超2500万元.

公司不仅拥有历史悠久的品牌、拥有雄厚的资金实力、拥有专业的管理人才、拥有完善的产业化基础、更拥有强大的新产品研发能力.仅在厦门一地就有研发技术人员56人,其中博士研究生1人,硕士5人,高级工程师7人,工程师39人.同时我们还以优越政策积极吸引国内外专家的加入,多年来金日在新产品方面的巨大投入,,吸引了众多国内外医药研究团队,例如中国药科大学中药研究中心、上海第二军医大学临床医学研究中心、上海医药工业研究院制剂工程中心、上海中医药大学、南京中医药大学健康研究中心以及世界卫生组织心血管病研究基地,形成了完美的“产学研”研发模式.

为了实现研发能力的进一步提速和升级,集团决定2007年在厦门建设金日制药二厂,投资人民币2亿多,并争取厦门市政府和国家科技部的支持,用时3-5年在厦门建立一个海西中药现代化工程中心.公司不仅要成为保健品领域的“常青树”,更将致力于打造国际一体化的现代中药产业链.

我们秉承“建一流企业,创一流产品”的宗旨,继续弘扬“诚信求实、开拓创新、锐意进取、奉献社会”的企业精神,不断超越自我,创造新的辉煌.

英文翻译:Jinri is a diversified industrial group with a history of more than 20 years, integrating pharmacy, medical treatment, health care, finance, trade and real estate. It has more than ten subordinate enterprises in Hong Kong and the mainland, and has carried out various investment and trade activities in Singapore, Canada and other places. It has established manufacturing bases in Xiamen, Fuzhou, Shunde, Shenzhen and other places in China, with a total investment of 1 billion yuan in 1986, Xiamen kingri Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the group, was founded in 1991. Now it has 9 production lines that meet the international GMP standards, including oral liquid, tablet, capsule, granule, coagulant, extract, cream, cataplasm, membrane, etc, It is the largest modern pharmaceutical enterprise in Fujian Province that has passed the GMP certification. With more than 20 years of brand building, it has made the "golden day" brand series products famous at home and abroad. The "golden day" brand has become a well-known brand in China's foreign ginseng industry,, Known as the "king of American ginseng" in Southeast Asia, Jinri Xinyuansu has become the first brand of China's heart and brain health care. The company's development process has been affirmed and praised by Li Ruihuan, Wan Li, Yang Chengwu, Wang Guangying, Wang Zhaoguo, Qian Weichang, Wan Guoquan, Wang Hanbin, Cheng Siyuan, BuChE, WuJie equal party and state leaders. The company has been rated as the second foreign-invested enterprise in Xiamen Top 10, top 10 pharmaceutical enterprises in Fujian Province, top 50 health food enterprises in China, top 100 star overseas Chinese enterprises in China, and over 25 million yuan of tax payment for five consecutive years. The company not only has a long history of brand, has a strong financial strength, has professional management personnel, has a sound industrialization foundation, but also has a strong ability of new product research and development. There are research and development technologies in Xiamen alone There are 56 personnel, including 1 doctoral student, 5 Master's degree, 7 senior engineers and 39 engineers. At the same time, we actively attract experts from home and abroad to join us with superior policies. Over the years, Jin RI has invested heavily in new products and attracted many domestic and foreign pharmaceutical research teams, For example, Chinese medicine research center of China Pharmaceutical University, clinical medicine research center of Shanghai Second Military Medical University, preparation engineering center of Shanghai Pharmaceutical Industry Research Institute, Shanghai University of traditional Chinese medicine, health research center of Nanjing University of traditional Chinese medicine and cardiovascular disease research base of World Health Organization, A perfect "production, learning and research" R & D mode has been formed. In order to further speed up and upgrade the R & D capacity, the group decided to build Jinri pharmaceutical No.2 factory in Xiamen in 2007, invest more than 200 million yuan, and strive for the support of Xiamen municipal government and the Ministry of science and technology of the people's Republic of China. In 3-5 years, it will establish a Haixi modern engineering center of traditional Chinese medicine in Xiamen. The company will not only become the "evergreen tree" in the field of health products, We will be committed to building an international integrated modern Chinese medicine industry chain. Adhering to the tenet of "building a first-class enterprise and creating a first-class product", we will continue to carry forward the enterprise spirit of "honesty and truth-seeking, pioneering and innovation, forge ahead with determination and dedication to the society", constantly surpass ourselves and create a new brilliance

本文链接: https://www.waitui.com/brand/8b9200320.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

宏润建设:股东周美珍计划减持不超0.12%股份

36氪获悉,宏润建设公告,股东周美珍因个人资金需求,计划自公告披露之日起十五个交易日后的三个月内,即2026年1月30日至2026年4月29日,通过集中竞价交易方式减持公司股份不超过150.10万股,占剔除公司回购专用账户股份后总股本的0.12%。减持股份来源:因离婚财产分割、通过非交易过户取得的股份。

2小时前

欧盟反垄断监管机构定于2月10日前就谷歌收购Wiz的交易作出裁决

据欧盟委员会网站公示文件,欧盟反垄断监管机构将于2月10日前裁定,是否批准Alphabet以320亿美元收购网络安全公司Wiz的交易,这也是Alphabet有史以来规模最大的一笔收购。(新浪财经)

2小时前

谱尼测试:股票交易严重异常波动 预计2025年度亏损2亿元-2.5亿元

36氪获悉,谱尼测试公告,公司股票自2025年12月24日至2026年1月8日连续10个交易日内日收盘价格涨幅偏离值累计达到+100%,属于股票交易严重异常波动的情况。公司预计2025年度亏损2亿元到2.5亿元。经核实,公司不存在违反信息公平披露的情形,也无应披露而未披露的重大事项或处于筹划阶段的重大事项。公司提醒广大投资者理性投资,注意投资风险。

2小时前

美股大型科技股盘前涨跌不一,苹果跌超1%

36氪获悉,美股大型科技股盘前涨跌不一,截至发稿,苹果跌超1%,特斯拉跌0.88%,微软跌0.64%,Meta跌0.43%,奈飞跌0.32%;谷歌涨0.91%,英伟达涨0.31%,亚马逊涨0.23%。

2小时前

热门中概股美股盘前多数下跌,哔哩哔哩涨近3%

36氪获悉,热门中概股美股盘前多数下跌,截至发稿,拼多多、百度、爱奇艺跌超1%,京东跌0.72%,阿里巴巴跌0.48%,理想汽车跌0.35%,哔哩哔哩涨近3%,小鹏汽车涨超1%,蔚来涨0.21%。

2小时前

本页详细列出关于金日的品牌信息,含品牌所属公司介绍,金日所处行业的品牌地位及优势。
咨询